On May 13, 2022, World Health Organization(WHO) Position Paper on Influenza Vaccine (2022 edition) was published. This position paper updates information on influenza epidemiology, high risk population, the impact of immunization on disease, influenza vaccines and effectiveness and safety, and propose WHO's position and recommendation that all countries should consider implementing seasonal influenza vaccine immunization programmes to prepare for an influenza pandemic. In addition, it proposes that the influenza surveillance platform can be integrated with the surveillance of other respiratory viruses, such as SARS-CoV-2 and Respiratory Syncytial Virus. This position paper has some implications for the prevention and control of influenza and other respiratory infectious diseases in China: (1) Optimize influenza vaccine policies to facilitate the implementation of immunization services; (2) Influenza prevention and control should from the perspective of Population Medicine focus on the individual and community to integrate with "Promotion, Prevention, Diagnosis, Control, Treatment, Rehabilitation"; (3) Incorporate prevention and control of other respiratory infectious diseases such as influenza, COVID-19, respiratory syncytial virus and adenovirus, and intelligently monitor by integrating multi-channel data to achieve the goal of co-prevention and control of multiple diseases.
2022年5月13日，《世界卫生组织流感疫苗立场文件（2022年版）》（以下简称立场文件）发布。本文总结了立场文件更新的主要内容，包括流感流行病学、风险人群、免疫接种对疾病的影响、流感疫苗及其效果与安全性，世界卫生组织的立场等，推荐各国均应考虑实施流感疫苗免疫规划项目以应对流感大流行。此外，还提出流感监测平台可与新型冠状病毒、呼吸道合胞病毒等其他呼吸道病毒监测整合。分析了对我国流感等呼吸道传染病防控和疫苗接种的启示：（1）优化流感疫苗政策，以促进免疫服务的实施；（2）流感防控应从群医学角度，关注个体和群体“促防诊控治康”一体化；（3）应将流感、新冠、呼吸道合胞病毒、腺病毒等呼吸道传染病联合防控，整合利用多渠道数据，建立多渠道监测和智慧化预警技术和平台，实现多病共防共控。.